-
Barron's Picks And Pans: BioMarin, Caesars, Royal Caribbean And More
Sunday, January 26, 2020 - 10:55am | 680Read More...This weekend's Barron's cover story offers ways for investors to play the surge in legal sports gambling. Other featured articles include some stock picks from Barron's Roundtable panelists. Also, a second look at energy stocks, the best plays in esports, investing in car chip stocks...
-
More Wild Short Interest Swings In Biotech Stocks
Sunday, December 13, 2015 - 5:52pm | 924Read More...Short interest moves in leading biotech stocks were mixed in the most recent period. However, Illumina, Inc. (NASDAQ: ILMN) and Baxalta Inc (NYSE: BXLT) saw sharp increases in their short interest in late November. Short sellers appeared to lose interest in Juno Lighting LLC (NASDAQ: JUNO) late in...
-
Wild Short Interest Swings For These Three Biotech Stocks
Monday, October 12, 2015 - 3:17pm | 882Read More...Short interest changes in biotech stocks were mixed during the most recent period. Baxalta Inc (NYSE: BXLT) and Juno Therapeutics Inc (NASDAQ: JUNO) saw short interest surges in late September. Short interest in Medivation Inc (NASDAQ: MDVN) plunged during that time. With the ongoing market...
-
Why BioMarin Pharmaceutical Is Surging
Friday, March 27, 2015 - 11:22am | 275Read More...BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) jumped over 14 percent on Friday, as a buyout rumor surfaced just ahead of an apparently routine conference call with analysts concerning its developmental drug programs. Separately, Deutsche Bank's Robyn Karnauskas published a note on Friday...
-
Earnings Expectations For The Week Of April 28: Big Oil, Big Pharma And More
Sunday, April 27, 2014 - 11:58am | 854Read More...The earnings crunch continues this week. Among the highlights will be scheduled quarterly reports from Exxon Mobil and Chevron, from Bristol-Myers Squibb and Merck, from Time Warner and Viacom, and also from Twitter. Early Thursday, Exxon Mobil (NYSE: XOM) is expected to say that it had earnings...
-
Top Trending Tickers On StockTwits For February 18
Tuesday, February 18, 2014 - 11:22am | 592Read More...Here's a look at the top tickers trending on StockTwits.com. Forest Laboratories and Actavis: Major merger Investors woke up to news reports that Actavis (NYSE: ACT) has agreed to acquire Forest Laboratories (NYSE: FRX) for $25 billion in cash and stock. Investors will receive $26.04 in cash and...
-
Oppenheimer's Current Biotech Ratings
Monday, September 13, 2010 - 10:41am | 138Read More...Stock Prices as of September 10, 2010 Anadys Pharmaceuticals Inc. (NASDAQ: ANDS) $1.75, PERFORM BioMarin Pharmaceutical (NASDAQ: BMRN) $22.62, PERFORM Chelsea Therapeutics (NASDAQ: CHTP) $3.91, PERFORM Dynavax Technologies (NASDAQ: DVAX) $1.69, PERFORM Genzyme (NASDAQ: GENZ) $70.63, PERFORM...
